Hepatitis C, An Appraisal of Percutaneous Treatment of Liver Metastases, Current Information On Hepatitis C & treatments for the medical professional and patient.
An Appraisal of Percutaneous Treatment of Liver Metastases
|
|
table 1. Data Summary of the Study Patients
|
|
Patient No. |
Histotype |
Total Diameter at Presentation (cm) |
Ablation Treatment |
No. of Sessions |
Surgery Delay (mo) |
Total Diameter at Surgery (cm) |
Operation |
Tumoral Necrosis |
Follow-up, A/D (mo) |
|
1 |
Colonic carcinoma |
2 |
PEI |
4 |
5 |
5 |
RH + DR |
ND |
D (14) |
2 |
Leiomyosarcoma |
3 |
PEI |
2 |
8 |
8 |
RH |
ND |
A (19) |
3 |
Colonic carcinoma |
3.5 |
PEI |
3 |
4 |
8 |
LL |
ND |
A (15) |
4 |
Colonic carcinoma |
2 + 2 |
PEI |
4 |
7 |
5 |
RH + DR |
ND |
D (13) |
5 |
Carcinoid |
2.5* |
PEI/RF |
21 |
18 |
2 |
2-Stage hepat + DR |
80% |
A (8) |
6 |
Colonic carcinoma |
2 |
RF |
2 |
3 |
5 |
Bisegm + DR |
<20% |
A (8) |
7 |
Carcinoid |
2 |
RF |
3 |
2 |
3 |
Wedge |
50% |
A (5) |
8 |
Colonic carcinoma |
3 |
RF |
2 |
6 |
5 |
Wedge |
<20% |
A (3) |
|
Abbreviations: RH, right hepatectomy; LH, left lobectomy;
DR, diaphragmatic; ND, not determinable; A/D, alive/dead; 2-Stage
hepat, right hepatectomy (plus diaphragmatic excision) followed by
a left lobectomy 40 days later; Bisegm, bisegmentectomy.
* Value expressed as mean. |
|
Return To Article